AdaptHealth (AHCO) Aperçu de l'action
AdaptHealth Corp. et ses filiales distribuent des équipements médicaux à domicile, des fournitures médicales et des services à domicile et connexes aux États-Unis. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 6/6 |
| Croissance future | 3/6 |
| Performances passées | 0/6 |
| Santé financière | 2/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
Aucun risque n'a été détecté pour AHCO à partir de nos contrôles de risques.
AHCO Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
AdaptHealth Corp. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$10.22 |
| Plus haut sur 52 semaines | US$13.43 |
| Plus bas sur 52 semaines | US$8.51 |
| Bêta | 1.45 |
| Variation sur 1 mois | 0.59% |
| Variation sur 3 mois | -17.05% |
| Variation sur 1 an | 10.85% |
| Variation sur 3 ans | -23.50% |
| Variation sur 5 ans | -59.87% |
| Évolution depuis l'introduction en bourse | 6.46% |
Nouvelles et mises à jour récentes
Mise à jour du récit • Jul 06
AHCO: Cyber Resilience And Execution Will Support Future Cash Flow Repricing
The updated analyst price target for AdaptHealth has been revised from $18 to $16, as analysts factor in the recent cyberattack while still reflecting modestly adjusted expectations for revenue growth, profit margins, and future P/E assumptions. Analyst Commentary Recent research on AdaptHealth shows a mix of cautious adjustments and ongoing confidence, as bullish analysts refine their models in light of the cyberattack and other company specific developments.
Mise à jour du récit • Jun 22
AHCO: Tuck In Acquisitions And Refinancing Will Shape Future Earnings Profile
AdaptHealth’s latest Narrative Update reflects a modest adjustment to the analyst price target of around $11, as analysts incorporate slightly higher assumed revenue growth, profit margin, and discount rate, along with a marginally lower future P/E multiple in their models. Analyst Commentary on AdaptHealth Recent Street research on AdaptHealth points to a mixed but cautious tone.Mise à jour du récit • Jun 06
AHCO: Capitation Contract Execution Will Support Future Cash Flow Repricing
Narrative Update on AdaptHealth Analysts lifted the fair value estimate for AdaptHealth stock from $17 to $18, reflecting recent price target revisions across several firms that cite updated views on the company’s outlook and valuation assumptions. Analyst Commentary Recent Street research on AdaptHealth has centered on a series of price target resets, with several bullish analysts adjusting their models and one taking a more cautious stance.Mise à jour du récit • May 22
AHCO: Capitated Contract Investments And Legal Settlement Will Shape Future Earnings Profile
Analysts have nudged their average price target on AdaptHealth higher to about $11.00 from $9.50, reflecting updated views on valuation inputs such as a higher assumed future P/E multiple and recent mixed target changes across firms raising and lowering their dollar-based estimates. Analyst Commentary Recent Street research on AdaptHealth reflects a mix of optimism and caution, with some firms lifting price targets and others trimming them as they reassess assumptions around earnings quality, execution and balance sheet risk.Recent updates
Mise à jour du récit • Jul 06
AHCO: Cyber Resilience And Execution Will Support Future Cash Flow Repricing
The updated analyst price target for AdaptHealth has been revised from $18 to $16, as analysts factor in the recent cyberattack while still reflecting modestly adjusted expectations for revenue growth, profit margins, and future P/E assumptions. Analyst Commentary Recent research on AdaptHealth shows a mix of cautious adjustments and ongoing confidence, as bullish analysts refine their models in light of the cyberattack and other company specific developments.Mise à jour du récit • Jun 22
AHCO: Tuck In Acquisitions And Refinancing Will Shape Future Earnings Profile
AdaptHealth’s latest Narrative Update reflects a modest adjustment to the analyst price target of around $11, as analysts incorporate slightly higher assumed revenue growth, profit margin, and discount rate, along with a marginally lower future P/E multiple in their models. Analyst Commentary on AdaptHealth Recent Street research on AdaptHealth points to a mixed but cautious tone.Mise à jour du récit • Jun 06
AHCO: Capitation Contract Execution Will Support Future Cash Flow Repricing
Narrative Update on AdaptHealth Analysts lifted the fair value estimate for AdaptHealth stock from $17 to $18, reflecting recent price target revisions across several firms that cite updated views on the company’s outlook and valuation assumptions. Analyst Commentary Recent Street research on AdaptHealth has centered on a series of price target resets, with several bullish analysts adjusting their models and one taking a more cautious stance.Mise à jour du récit • May 22
AHCO: Capitated Contract Investments And Legal Settlement Will Shape Future Earnings Profile
Analysts have nudged their average price target on AdaptHealth higher to about $11.00 from $9.50, reflecting updated views on valuation inputs such as a higher assumed future P/E multiple and recent mixed target changes across firms raising and lowering their dollar-based estimates. Analyst Commentary Recent Street research on AdaptHealth reflects a mix of optimism and caution, with some firms lifting price targets and others trimming them as they reassess assumptions around earnings quality, execution and balance sheet risk.Mise à jour du récit • Apr 25
AHCO: Capitated Contract Ramp And Legal Settlement Will Pressure Future Earnings
Analysts have nudged their price targets for AdaptHealth higher by about $1 to $1.50, citing updated views on discount rates, revenue growth, profit margins, and future P/E assumptions reflected in the latest model tweaks. Analyst Commentary Recent research updates show a mixed but generally cautious tone around AdaptHealth, even as some targets move higher at the margin.Mise à jour du récit • Apr 10
AHCO: Capitation Contract Execution Will Drive Future Cash Flow Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent moves including cuts to $9.50 and $14. This reflects mixed views as they weigh operational progress, new capitation business, and recent EBITDA shortfalls and legal costs.Mise à jour du récit • Mar 27
AHCO: Forward Contract Ramp And Legal Settlement Will Pressure Profitability
Analysts have trimmed AdaptHealth's consensus price target by $1 to $9.50, reflecting updated views on fair value, discount rates, and profitability after recent operational and legal developments. Analyst Commentary Bearish analysts have recently reset expectations on AdaptHealth, trimming price targets and calling out execution risks tied to both operations and legal events.Mise à jour du récit • Mar 13
AHCO: Capitation Ramp And Cash Generation Will Drive Future Upside Potential
Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the impact of increased upfront investment in a major capitated contract and a debt collection settlement on near term earnings.Mise à jour du récit • Feb 27
AHCO: Capitation Ramp And Aging At Home Focus Will Support Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the company after operational progress in 2025 was offset by the timing of investments to ramp a large capitated contract and a debt collection legal settlement in North Carolina that affected adjusted EBITDA versus guidance and estimates.Mise à jour du récit • Feb 13
AHCO: Connected Health Initiative Will Support Aging At Home Upside
Analysts have kept their $17.00 price target for AdaptHealth unchanged, citing slightly adjusted assumptions around the discount rate, revenue growth, profit margins, and future P/E as the main reasons for maintaining their view. What's in the News AdaptHealth is participating in a new Digital Medicine Society initiative focused on using connected health technology to support independent living for older adults at home.Mise à jour du récit • Jan 30
AHCO: Digital Home Health Initiative Will Support Aging At Home Upside
Analysts are holding their fair value estimate for AdaptHealth at US$17.00 per share, citing only modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E that do not materially change their overall view. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for older adults living independently, working alongside partners including Validic, Epic Systems, Verizon and Withings to expand connected care and remote monitoring capabilities (Key Developments).Mise à jour du récit • Jan 16
AHCO: Digital Home Health Initiative Will Support Aging At Home Opportunity
Analysts have lifted their price target on AdaptHealth from US$16.00 to US$17.00 as they factor in updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for independent living among older adults, working alongside partners such as Validic, Epic Systems, Verizon, and Withings within the Connected Health Collaborative.Article d’analyse • Jan 03
AdaptHealth (NASDAQ:AHCO) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Oct 18
Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Article d’analyse • Aug 08
AdaptHealth Corp. Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
NasdaqCM:AHCO 1 Year Share Price vs Fair Value Explore AdaptHealth's Fair Values from the Community and select yours...Article d’analyse • Jul 23
Insufficient Growth At AdaptHealth Corp. (NASDAQ:AHCO) Hampers Share Price
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now...Article d’analyse • Jun 26
Is It Time To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it led the NASDAQCM gainers with a relatively...Seeking Alpha • Jun 02
AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care
Summary AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers. Long-term investors may find value in accumulating shares below 7× forward EBITDA, while monitoring integration milestones and CMS policy developments. Read the full article on Seeking Alpha
Nouveau récit • May 15
Adapt Operating System And Debt Reduction Will Transform Home Healthcare
AdaptHealth's focus on geographic expansion, managed care, and partnerships aims to boost market share and drive revenue growth in the home health industry.Article d’analyse • May 14
We Think AdaptHealth's (NASDAQ:AHCO) Solid Earnings Are Understated
AdaptHealth Corp.'s ( NASDAQ:AHCO ) recent earnings report didn't offer any surprises, with the shares unchanged over...Article d’analyse • May 09
AdaptHealth Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
AdaptHealth Corp. ( NASDAQ:AHCO ) last week reported its latest quarterly results, which makes it a good time for...Article d’analyse • Apr 07
Little Excitement Around AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing investment...Article d’analyse • Mar 20
At US$10.02, Is It Time To Put AdaptHealth Corp. (NASDAQ:AHCO) On Your Watch List?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it saw a decent share price growth of 19% on the...Article d’analyse • Feb 26
These 4 Measures Indicate That AdaptHealth (NASDAQ:AHCO) Is Using Debt Extensively
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d’analyse • Jan 30
Be Wary Of AdaptHealth (NASDAQ:AHCO) And Its Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Article d’analyse • Dec 10
AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Article d’analyse • Nov 13
We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Oct 22
Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Article d’analyse • Sep 06
AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
AdaptHealth Corp. ( NASDAQ:AHCO ) shareholders would be excited to see that the share price has had a great month...Article d’analyse • Jul 14
Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, AdaptHealth fair value estimate is US$16.89 Current share...Article d’analyse • Jun 25
AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Article d’analyse • Jun 04
AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Article d’analyse • Apr 03
Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Mar 07
Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost
AdaptHealth Corp. ( NASDAQ:AHCO ) shareholders would be excited to see that the share price has had a great month...Article d’analyse • Feb 16
AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Rendement pour les actionnaires
| AHCO | US Healthcare | US Marché | |
|---|---|---|---|
| 7D | -5.0% | -0.4% | 0.8% |
| 1Y | 10.8% | 31.5% | 20.6% |
Rendement vs Industrie: AHCO a sous-performé le secteur US Healthcare qui a rapporté 31.5 % au cours de l'année écoulée.
Rendement vs marché: AHCO a sous-performé le marché US qui a rapporté 20.6 % au cours de l'année écoulée.
Volatilité des prix
| AHCO volatility | |
|---|---|
| AHCO Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: AHCO n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de AHCO ( 5% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2012 | 10,900 | Suzanne Foster | adapthealth.com |
AdaptHealth Corp. et ses filiales distribuent des équipements médicaux à domicile, des fournitures médicales et des services à domicile et connexes aux États-Unis. Elle exerce ses activités dans les domaines de la santé du sommeil, de la santé respiratoire, de la santé du diabète et du bien-être à domicile. La société propose des équipements de thérapie du sommeil, des fournitures et des services connexes, tels que la pression positive continue et les services BiLevel pour les personnes souffrant d'apnée obstructive du sommeil ; des équipements et des fournitures pour l'oxygène et la ventilation mécanique à domicile et des services de thérapie chronique connexes ; des dispositifs médicaux, notamment des moniteurs de glucose en continu et des pompes à insuline pour le traitement du diabète ; des équipements médicaux d'urgence pour les patients sortant d'établissements de soins aigus et d'autres établissements ; et d'autres équipements médicaux d'urgence et des fournitures.
AdaptHealth Corp. Résumé des fondamentaux
| AHCO statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$1.36b |
| Bénéfices(TTM) | -US$79.63m |
| Recettes(TTM) | US$3.29b |
0.4x
Ratio P/S-17.1x
Ratio P/ELe site AHCO est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| AHCO compte de résultat (TTM) | |
|---|---|
| Recettes | US$3.29b |
| Coût des recettes | US$2.62b |
| Marge brute | US$670.35m |
| Autres dépenses | US$749.98m |
| Les revenus | -US$79.63m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.60 |
| Marge brute | 20.40% |
| Marge bénéficiaire nette | -2.42% |
| Ratio dettes/capitaux propres | 120.4% |
Quelles ont été les performances à long terme de AHCO?
Voir les performances historiques et les comparaisonsAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/07/12 08:56 |
| Cours de l'action en fin de journée | 2026/07/10 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d'analyse utilisé pour générer ce rapport sont disponibles sur notre page Github, nous proposons également des guides pour apprendre à utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
AdaptHealth Corp. est couverte par 11 analystes. 8 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Eric Coldwell | Baird |
| Kevin Fischbeck | BofA Global Research |
| Joanna Sylvia Gajuk | BofA Global Research |